Gerald W. Prager
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Para-aortic lymph nodes in oligometastatic pancreatic ductal adenocarcinoma - Authors' reply.
Journal: The Lancet. Oncology
Published: May 17, 2026
Management of colorectal cancer in older adults: an expert panel recommendation to guide daily clinical practice.
Journal: The lancet. Gastroenterology & hepatology
Published: November 27, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group).
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 11, 2025
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population.
Journal: Journal of the National Cancer Institute
Published: March 11, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 25, 2025
Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
Journal: Frontiers in oncology
Published: October 04, 2024
Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patients.
Journal: Molecular oncology
Published: December 15, 2023
A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.
Journal: Cancer research communications
Published: September 05, 2023
Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
Journal: The New England journal of medicine
Published: July 12, 2023
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Journal: The New England journal of medicine
Published: May 03, 2023
Third-line treatment strategies in metastatic colorectal cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: March 15, 2022
Optimizing administration of third-line treatment in metastatic colorectal cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: March 15, 2022
Last Updated: 09/26/2026